NEW YORK & LEXINGTON, Mass.--(BUSINESS WIRE)--Bristol-Myers Squibb Enters Agreement Providing Exclusive Right to Acquire Promedior, Inc. and its Novel PRM-151 in Development for Fibrotic Diseases